InsiderTrades

Form 4 for TNDM TANDEM DIABETES CARE INC

Accepted 2021-09-15 00:00:00 ET · period of report 2021-09-13 · accession 0001438133-21-000167 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-09-15 2021-09-13 TNDM Vosseller Leigh EVP, CFO M - OptEx $18.86 +10.0K 16.1K +163% +$188.6K
DM 2021-09-15 2021-09-13 TNDM Vosseller Leigh EVP, CFO S - Sale+OE $120.75 -10.0K 9,445 -51% -$1.21M
D 2021-09-15 2021-09-13 TNDM Vosseller Leigh EVP, CFO M - OptEx $18.86 +10.0K 55.2K +22% +$188.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-13 M A 10,000 $18.86 16,145 D — —
2 Common Common Stock 2021-09-13 S D 2,000 $122.39 6,145 D — — (F5) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $122.04 to $122.71. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
3 Common Common Stock 2021-09-13 S D 1,300 $121.38 8,145 D — — (F4) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $121.01 to $121.95. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
4 Common Common Stock 2021-09-13 S D 6,700 $120.14 9,445 D — — (F3) The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $120.00 to $120.67. The Reporting Person undertakes to provide the Securitiesand Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
5 Derivative Stock Option 2021-09-13 M A 10,000 $18.86 55,160 D $18.86 · — to — 10,000 Common Stock (F7) The options vested as to twenty-five (25%) of the underlying shares on 6/14/2019, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan"). (F8) The expiration date for these options is 10 years from the date of grant.